ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 404

Gut Microbiota Modify Inflammatory Arthritis through Autoantibody Generation and Mucosal Cytokines Alteration

Widian Jubair1, Sumitra Adhikari2, Nirmal Banda2 and Kristine Kuhn3, 1Rheumatology, University of Colorado, Aurora, CO, 2Division of Rheumatology, UC Denver School of Medicine, Denver, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoantibodies, cytokines and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Animal Models Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

The pathogenesis of rheumatoid arthritis (RA) is thought to be influenced by a combination of genetic and environmental factors. Observations of microbial dysbiosis in patients with RA have raised interest in studying microbial-mucosal interactions as a potential trigger of RA. Using the murine collagen-induced arthritis (CIA) model, which is dependent upon generation of T and B cell reactivity to CII as well as complement activation, we hypothesized that microbiota are required for the development of robust autoimmune arthritis.

Methods:

Male 6-week old DBA/1j mice were immunized with bovine type II collagen (CII) in Complete Freund’s Adjuvant (CFA) on days 0 and 21. Microbiota depletion was performed by continuous administration of broad spectrum antibiotics in drinking water early (7 days preceding and throughout the study) or late (starting after day 21 throughout the study) in the disease process. Microbial depletion was confirmed by quantifying bacterial 16S rRNA by qPCR in feces. Sera were collected every 7 days during the study for autoantibody and cytokine testing. Mice were euthanized on day 35 and intestinal tissues were harvested for cytokine analyses by ELISA. Disease severity starting at day 21 was assessed by assigning a score for the degree of paw swelling.

Results:

Depletion of the microbiota prior to the induction of CIA resulted in ~50% reduction in disease severity associated with significantly reduced serum inflammatory cytokines and anti-CII antibodies. In intestinal tissue, we observed delayed IL-17A and IL-22 responses. Unexpectedly, microbial depletion during the late, effector phase of CIA resulted in >90% decrease in disease severity and 50% reduction in prevalence. In these mice, anti-CII antibodies were mildly reduced, but were significantly impaired in their ability to activate complement. In addition to reduced systemic inflammatory cytokines and intestinal IL-17A and IL-22, IL-23 was significantly reduced, suggesting it may link mucosal immune responses with systemic autoantibody effectivity. Studies are now aimed at understanding this mechanism.

Conclusion:

While future studies are needed to solidify the role of the microbiota in driving CIA, our data supports a model in which intestinal dysbiosis triggers mucosal immune responses that stimulate systemic B cell activities that are key for the development of inflammatory arthritis. Understanding the pathway by which microbiota and mucosal immune responses modulate systemic autoantibody production is pivotal, as targeting the microbiota during the preclinical, seropositive phase of RA may have potential for disease prevention.


Disclosure: W. Jubair, None; S. Adhikari, None; N. Banda, None; K. Kuhn, None.

To cite this abstract in AMA style:

Jubair W, Adhikari S, Banda N, Kuhn K. Gut Microbiota Modify Inflammatory Arthritis through Autoantibody Generation and Mucosal Cytokines Alteration [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/gut-microbiota-modify-inflammatory-arthritis-through-autoantibody-generation-and-mucosal-cytokines-alteration/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbiota-modify-inflammatory-arthritis-through-autoantibody-generation-and-mucosal-cytokines-alteration/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology